884535-05-1

Basic information

• Product Name: [4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride
• Synonyms: [4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride;Piperidine-4,4-diyldimethanol hydrochloride;[4-(hydroxymethyl)-4-piperidyl]methanol hydrochloride;4,4-PIPERIDINEDIYLDIMETHANOL HCL;4,4-piperidinediyldimethanol hydrochloride
• CAS NO: 884535-05-1
• Molecular Formula: C₇H₁₅NO₂*ClH
• Molecular Weight: 181.66044
• Mol File: 884535-05-1.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: [4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride(884535-05-1)
• EPA Substance Registry System: [4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride(884535-05-1)

Safety Data

• Hazardous Substances Data: 884535-05-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
[4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride is used as a building block for the synthesis of various drugs, including antipsychotics and other central nervous system medications, due to its role in creating the desired molecular structures.
Used in Chemical Industry:
[4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride is used as a reagent in organic synthesis and as an intermediate in the production of other chemical compounds, contributing to the development of new chemical entities.
Used in Compound Stability and Solubility Enhancement:
[4-(hydroxymethyl)piperidin-4-yl]methanol hydrochloride is used in its hydrochloride salt form to increase the stability and solubility of the compound, making it easier to handle and use in various applications.

Upstream product

• 137076-22-3 tert butyl 4-formylpiperidine-1-carboxylate 
• 374794-84-0 tert-butyl 4,4-bis(hydroxymethyl)piperidine-1-carboxylate 

Downstream Products

• 916588-30-2 cinnamic norbornene methyl ester 

Relevant articles and documents

SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES

Novel non-nucleoside solid supports and phosphoramidite building blocks for preparation of synthetic oligonucleotides containing at least one non-nucleosidic moiety conjugated to a ligand of practical interest and synthetic processes for making the same are disclosed. Furthermore, oligomeric compounds are prepared using said solid supports and phosphoramidite building blocks, preferably followed by removal of protecting groups to provide oligonucleotides conjugated to ligands of interest.

NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF

The present invention relates to compounds of formula I or pharmaceutically acceptable salt, solvate or hydrate thereof and their use in methods of treating or preventing a disease alleviated by inhibition of PDE5 in a human or in a non-human mammal.

AROMATIC-RING-FUSED PYRIMIDINE DERIVATIVE

There are provided novel pyrimidine derivatives which has been fused with an aromatic heterocycle selected from thiophene, thiazole and pyridine or pharmaceutically acceptable salts thereof; and a pharmaceutical composition comprising said compound as an

PYRIMIDINE DERIVATIVE CONDENSED WITH NON-AROMATIC RING

There are provided new pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety, and the like or pharmaceutically acceptable salts thereof; and a pharmaceutical composition comprising said